Aug 2026· International Journal of Cardiology· Vol 463, pp.
134750
· 1 citation· 29 references
Medicine
TL;DR
In patients with non-obstructive coronary arteries undergoing ACH testing, endothelial dysfunction and a MINOCA presentation were independently associated with adverse events, whereas classical spasm endotypes were not.
Abstract
Background
There is little information regarding the characteristics of patients with myocardial infarction with non-obstructive coronary arteries (MINOCA) in terms of coronary endothelial function and prognosis, as compared to patients with angina and non-obstructive coronaries (ANOCA). We assessed differences in clinical profile, endothelial function and prognosis between patients undergoing acetylcholine (ACH) testing for MINOCA or ANOCA.
Methods
We combined two cohorts of patients undergoing ACH testing - ENDOCOR (multicentre; 2015-2023) and FISIOTON (single-centre; 2018-2024) - totalling 723 patients. Endothelial dysfunction was defined as any epicardial vasoconstriction to ACH or endothelium-dependent coronary flow reserve ≤1.5.
Results
MINOCA was diagnosed in 68 (9.4%) patients. Endothelial dysfunction was found in 57.4%, epicardial spasm in 7.05% and microvascular spasm in 1.94%, without differences between MINOCA and ANOCA. In multivariable regression, MINOCA was independently associated with resting chest pain (OR 3.63, 95% CI: 1.84-7.66), previous MI (OR 2.91, 95% CI: 1.29-6.30) and active smoking (OR 2.15, 95% CI: 1.04-4.30). Over a median follow-up of 3.0 years, major adverse cardiovascular events (MACE) occurred in 7.5% of patients. MINOCA (HR 2.81, 95% CI: 1.40-5.67, p = 0.004), endothelial dysfunction (HR 2.59, 95% CI: 1.29-5.21, p = 0.008) and male sex (HR 2.01, 95% CI: 1.13-3.58, p = 0.017) were independently associated with MACE. Patients with MINOCA and endothelial dysfunction had the highest event rate (19.4%).
Conclusions
In patients with non-obstructive coronary arteries undergoing ACH testing, endothelial dysfunction and a MINOCA presentation were independently associated with adverse events, whereas classical spasm endotypes were not.
BACKGROUND
Myocardial infarction with nonobstructive coronary arteries (MINOCAs) and angina with nonobstructive coronary arteries (ANOCAs) present diagnostic and therapeutic challenges. We assessed the frequency of coronary microvascular disease (CMD) and its subtypes in MINOCA compared with ANOCA and evaluated long-te...
Justin G. Carrington, K. Nogami, Y. Kanaji et al.· Circulation. Cardiovascular...· 0 citations
Some studies showed that the prognosis for patients with Myocardial Infarction (MI) with Non-Obstructive Coronary Artery Disease (MINOCA) is more favourable compared to those with Obstructive Coronary Artery Disease (MI-CAD). However, it has been proven to be worse than the general population.
Evaluate the...
M. Ferreira, M. Mendonca, G. Abreu et al.· European Heart Journal· 0 citations
Importance
Coronary microvascular dysfunction (CMD) is highly prevalent in patients with angina and nonobstructive coronary arteries (ANOCA). Microvascular resistance reserve (MRR) is a novel index to assess CMD independently of epicardial disease and driving pressures, but the long-term prognostic value of continuous...
B. Yosofi, A. Mechroubi, A. D. de Vos et al.· JAMA cardiology· 0 citations
Coronary vasomotor dysfunction is the main cause of angina and no obstructive coronary artery disease (ANOCA), involving epicardial and/or microvascular vasospasm and coronary microvascular dysfunction (CMD). Invasive coronary function testing enables classification of CMD into structural, functional, and compens...
R. Verduijn, P. Winkler, Á. Lux et al.· European Heart Journal· 0 citations
Most women evaluated for angina have no obstructive coronary artery disease (ANOCA), yet many have persistent symptoms1, and the long-term burden of angina-related healthcare utilization remains poorly defined. Coronary microvascular dysfunction (CMD), reflected by impaired coronary flow velocity reserve (CFVR),...
L. Rytoft, N. Mygind, T. Holmager et al.· European Heart Journal· 0 citations
Coronary microvascular dysfunction (CMD) refers to a broad spectrum of structural and functional abnormalities of the coronary microcirculation and, in clinical practice, is commonly defined by impaired flow augmentation in response to a pharmacological vasodilator in the presence of nonobstructive coronary arter...
A. Sakalidis, K. Dimitriadis, E. Adamopoulou et al.· European Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.